Stopping rules for phase II studies.

Abstract

This paper, the second in a series of three papers concerned with the statistical aspects of interim analyses in clinical trials, is concerned with stopping rules in phase II clinical trials. Phase II trials are generally small-scale studies, and may include one or more experimental treatments with or without a control. A common feature is that the results… (More)

Topics

Cite this paper

@article{Stallard2001StoppingRF, title={Stopping rules for phase II studies.}, author={Nigel Stallard and J. K. Whitehead and S. Todd and A. Whitehead}, journal={British journal of clinical pharmacology}, year={2001}, volume={51 6}, pages={523-9} }